Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Voxel-based identification of local recurrence sub-regions from pre-treatment PET/CT for locally advanced head and neck cancers.

Beaumont J, Acosta O, Devillers A, Palard-Novello X, Chajon E, de Crevoisier R, Castelli J.

EJNMMI Res. 2019 Sep 18;9(1):90. doi: 10.1186/s13550-019-0556-z.

2.

Comparison of Deep Learning-Based and Patch-Based Methods for Pseudo-CT Generation in MRI-Based Prostate Dose Planning.

Largent A, Barateau A, Nunes JC, Mylona E, Castelli J, Lafond C, Greer PB, Dowling JA, Baxter J, Saint-Jalmes H, Acosta O, de Crevoisier R.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1137-1150. doi: 10.1016/j.ijrobp.2019.08.049. Epub 2019 Sep 7.

PMID:
31505245
3.

Multi T1-weighted contrast MRI with fluid and white matter suppression at 1.5 T.

Beaumont J, Saint-Jalmes H, Acosta O, Kober T, Tanner M, Ferré JC, Salvado O, Fripp J, Gambarota G.

Magn Reson Imaging. 2019 Nov;63:217-225. doi: 10.1016/j.mri.2019.08.010. Epub 2019 Aug 16.

PMID:
31425812
4.

The Current Genomic Landscape of Western South America: Andes, Amazonia, and Pacific Coast.

Barbieri C, Barquera R, Arias L, Sandoval JR, Acosta O, Zurita C, Aguilar-Campos A, Tito-Álvarez AM, Serrano-Osuna R, Gray RD, Mafessoni F, Heggarty P, Shimizu KK, Fujita R, Stoneking M, Pugach I, Fehren-Schmitz L.

Mol Biol Evol. 2019 Dec 1;36(12):2698-2713. doi: 10.1093/molbev/msz174.

5.

Deformable image registration for radiation therapy: principle, methods, applications and evaluation.

Rigaud B, Simon A, Castelli J, Lafond C, Acosta O, Haigron P, Cazoulat G, de Crevoisier R.

Acta Oncol. 2019 Sep;58(9):1225-1237. doi: 10.1080/0284186X.2019.1620331. Epub 2019 Jun 3.

PMID:
31155990
6.

Voxel-Based Analysis for Identification of Urethrovesical Subregions Predicting Urinary Toxicity After Prostate Cancer Radiation Therapy.

Mylona E, Acosta O, Lizee T, Lafond C, Crehange G, Magné N, Chiavassa S, Supiot S, Ospina Arango JD, Campillo-Gimenez B, Castelli J, de Crevoisier R.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):343-354. doi: 10.1016/j.ijrobp.2019.01.088. Epub 2019 Feb 2.

PMID:
30716523
7.

In Reply.

Liu J, Murray AM, Mankus EB, Ireland KE, Acosta OM, Ramsey PS.

Obstet Gynecol. 2019 Feb;133(2):385. doi: 10.1097/AOG.0000000000003096. No abstract available.

PMID:
30681533
8.

Pseudo-CT Generation for MRI-Only Radiation Therapy Treatment Planning: Comparison Among Patch-Based, Atlas-Based, and Bulk Density Methods.

Largent A, Barateau A, Nunes JC, Lafond C, Greer PB, Dowling JA, Saint-Jalmes H, Acosta O, de Crevoisier R.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):479-490. doi: 10.1016/j.ijrobp.2018.10.002. Epub 2018 Oct 16.

PMID:
30336265
9.

PET-based prognostic survival model after radiotherapy for head and neck cancer.

Castelli J, Depeursinge A, Devillers A, Campillo-Gimenez B, Dicente Y, Prior JO, Chajon E, Jegoux F, Sire C, Acosta O, Gherga E, Sun X, De Bari B, Bourhis J, de Crevoisier R.

Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):638-649. doi: 10.1007/s00259-018-4134-9. Epub 2018 Aug 21.

PMID:
30132054
10.

Statistical Shape Model to Generate a Planning Library for Cervical Adaptive Radiotherapy.

Rigaud B, Simon A, Gobeli M, Leseur J, Duverge L, Williaume D, Castelli J, Lafond C, Acosta O, Haigron P, De Crevoisier R.

IEEE Trans Med Imaging. 2019 Feb;38(2):406-416. doi: 10.1109/TMI.2018.2865547. Epub 2018 Aug 16.

11.

Adjuvant Use of Rifampin for Refractory Intrahepatic Cholestasis of Pregnancy.

Liu J, Murray AM, Mankus EB, Ireland KE, Acosta OM, Ramsey PS.

Obstet Gynecol. 2018 Sep;132(3):678-681. doi: 10.1097/AOG.0000000000002794.

PMID:
30095766
12.

Identifying Risk Factors for Cesarean Delivery in a Predominantly Hispanic Teenage Population: A 5-Year Retrospective Study.

Oben AG, Batiste O, Fokong K, Davidson S, Acosta OM.

J Pediatr Adolesc Gynecol. 2018 Oct;31(5):485-489. doi: 10.1016/j.jpag.2018.05.001. Epub 2018 May 16.

PMID:
29753776
13.

Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis.

Molina-Molina M, Aburto M, Acosta O, Ancochea J, Rodríguez-Portal JA, Sauleda J, Lines C, Xaubet A.

Expert Rev Respir Med. 2018 Jul;12(7):537-539. doi: 10.1080/17476348.2018.1472580. Epub 2018 May 7. No abstract available.

PMID:
29718749
14.

Role of quantitative computed tomography texture analysis in the prediction of adherent perinephric fat.

Khene ZE, Bensalah K, Largent A, Shariat S, Verhoest G, Peyronnet B, Acosta O, DeCrevoisier R, Mathieu R.

World J Urol. 2018 Oct;36(10):1635-1642. doi: 10.1007/s00345-018-2292-9. Epub 2018 Apr 19.

PMID:
29675631
15.

Glycine Increases Insulin Sensitivity and Glutathione Biosynthesis and Protects against Oxidative Stress in a Model of Sucrose-Induced Insulin Resistance.

El-Hafidi M, Franco M, Ramírez AR, Sosa JS, Flores JAP, Acosta OL, Salgado MC, Cardoso-Saldaña G.

Oxid Med Cell Longev. 2018 Feb 21;2018:2101562. doi: 10.1155/2018/2101562. eCollection 2018.

16.

Genetic ancestry of families of putative Inka descent.

Sandoval JR, Lacerda DR, Jota MS, Elward R, Acosta O, Pinedo D, Danos P, Cuellar C, Revollo S, Santos FR, Fujita R.

Mol Genet Genomics. 2018 Aug;293(4):873-881. doi: 10.1007/s00438-018-1427-4. Epub 2018 Mar 3.

17.

Purification of a fragment obtained by autolysis of a PIIIb-SVMP from Bothrops alternatus venom.

Van de Velde AC, Gay CC, Moritz MNO, Dos Santos PK, Bustillo S, Rodríguez JP, Acosta OC, Biscoglio MJ, Selistre-de-Araujo HS, Leiva LC.

Int J Biol Macromol. 2018 Jul 1;113:205-211. doi: 10.1016/j.ijbiomac.2018.02.063. Epub 2018 Feb 19. No abstract available.

PMID:
29471097
18.

[External beam radiotherapy cone beam-computed tomography-based dose calculation].

Barateau A, Céleste M, Lafond C, Henry O, Couespel S, Simon A, Acosta O, de Crevoisier R, Périchon N.

Cancer Radiother. 2018 Feb;22(1):85-100. doi: 10.1016/j.canrad.2017.07.050. Epub 2017 Dec 21. Review. French.

19.

Evaluation of pro-inflammatory events induced by Bothrops alternatus snake venom.

Echeverría S, Leiguez E, Guijas C, do Nascimento NG, Acosta O, Teixeira C, Leiva LC, Rodríguez JP.

Chem Biol Interact. 2018 Feb 1;281:24-31. doi: 10.1016/j.cbi.2017.12.022. Epub 2017 Dec 14.

PMID:
29248447
20.

Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapy.

Fargeas A, Acosta O, Ospina Arrango JD, Ferhat A, Costet N, Albera L, Azria D, Fenoglietto P, Créhange G, Beckendorf V, Hatt M, Kachenoura A, de Crevoisier R.

Radiother Oncol. 2018 Feb;126(2):263-269. doi: 10.1016/j.radonc.2017.11.011. Epub 2017 Dec 5.

PMID:
29203291
21.

The influence of different peptide combinations to increase the immunogenicity of the Gonadotrophin Releasing Hormone Vaccine for prostate cancer treatment.

Aguilar FF, Barranco JJ, Aguilera LC, Fuentes EB, Serradelo Leal JA, López EH, Vázquez EP, Baker RB, Acosta OR, Pérez HG, Nieto GG.

J Exp Ther Oncol. 2017 Nov;12(2):87-94.

PMID:
29161775
22.

Palliative Care in Diffuse Interstitial Lund Disease: Results of a Spanish Survey.

Barril S, Alonso A, Rodríguez-Portal JA, Viladot M, Giner J, Aparicio F, Romero-Ortiz A, Acosta O, Castillo D.

Arch Bronconeumol. 2018 Mar;54(3):123-127. doi: 10.1016/j.arbres.2017.08.007. Epub 2017 Nov 8. English, Spanish.

23.

Docosahexaenoic Acid Supplementation in Pregnancy Modulates Placental Cellular Signaling and Nutrient Transport Capacity in Obese Women.

Lager S, Ramirez VI, Acosta O, Meireles C, Miller E, Gaccioli F, Rosario FJ, Gelfond JAL, Hakala K, Weintraub ST, Krummel DA, Powell TL.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4557-4567. doi: 10.1210/jc.2017-01384.

24.

Multi-atlas-based segmentation of prostatic urethra from planning CT imaging to quantify dose distribution in prostate cancer radiotherapy.

Acosta O, Mylona E, Le Dain M, Voisin C, Lizee T, Rigaud B, Lafond C, Gnep K, de Crevoisier R.

Radiother Oncol. 2017 Dec;125(3):492-499. doi: 10.1016/j.radonc.2017.09.015. Epub 2017 Oct 12.

25.

Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.

Buleje J, Guevara-Fujita M, Acosta O, Huaman FDP, Danos P, Murillo A, Pinto JA, Araujo JM, Aguilar A, Ponce J, Vigil C, Castaneda C, Calderon G, Gomez HL, Fujita R.

Mol Genet Genomic Med. 2017 Jun 28;5(5):481-494. doi: 10.1002/mgg3.301. eCollection 2017 Sep.

26.

Erratum to "Guidelines for the medical treatment of idiopathic pulmonary fibrosis" <[Arch Bronconeumol. 53 (2017) 263-9] >.

Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J.

Arch Bronconeumol. 2017 Nov;53(11):657-658. doi: 10.1016/j.arbres.2017.06.010. Epub 2017 Sep 18. English, Spanish. No abstract available.

27.

[MRI-based radiotherapy planning].

Largent A, Nunes JC, Lafond C, Périchon N, Castelli J, Rolland Y, Acosta O, de Crevoisier R.

Cancer Radiother. 2017 Dec;21(8):788-798. doi: 10.1016/j.canrad.2017.02.007. Epub 2017 Jul 6. Review. French.

PMID:
28690126
28.

Partial volume model for brain MRI scan using MP2RAGE.

Duché Q, Saint-Jalmes H, Acosta O, Raniga P, Bourgeat P, Doré V, Egan GF, Salvado O.

Hum Brain Mapp. 2017 Oct;38(10):5115-5127. doi: 10.1002/hbm.23719. Epub 2017 Jul 5.

PMID:
28677254
29.

Nomogram to predict rectal toxicity following prostate cancer radiotherapy.

Delobel JB, Gnep K, Ospina JD, Beckendorf V, Chira C, Zhu J, Bossi A, Messai T, Acosta O, Castelli J, de Crevoisier R.

PLoS One. 2017 Jun 22;12(6):e0179845. doi: 10.1371/journal.pone.0179845. eCollection 2017.

30.

Intra-amniotic Dye Alternatives for the Diagnosis of Preterm Prelabor Rupture of Membranes.

Ireland KE, Rodriguez EI, Acosta OM, Ramsey PS.

Obstet Gynecol. 2017 Jun;129(6):1040-1045. doi: 10.1097/AOG.0000000000002056.

PMID:
28486367
31.

Effect of Water Activity on the Thermal Tolerance and Survival of Salmonella enterica Serovars Tennessee and Senftenberg in Goat's Milk Caramel.

Acosta O, Usaga J, Churey JJ, Worobo RW, Padilla-Zakour OI.

J Food Prot. 2017 Jun;80(6):922-927. doi: 10.4315/0362-028X.JFP-16-191.

PMID:
28459616
32.

Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation.

Castillo LM, Guerrero CA, Acosta O.

J Mol Histol. 2017 Jun;48(3):169-185. doi: 10.1007/s10735-017-9717-4. Epub 2017 Mar 25.

PMID:
28343338
33.

Population model of bladder motion and deformation based on dominant eigenmodes and mixed-effects models in prostate cancer radiotherapy.

Rios R, De Crevoisier R, Ospina JD, Commandeur F, Lafond C, Simon A, Haigron P, Espinosa J, Acosta O.

Med Image Anal. 2017 May;38:133-149. doi: 10.1016/j.media.2017.03.001. Epub 2017 Mar 8.

34.

Guidelines for the medical treatment of idiopathic pulmonary fibrosis.

Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J.

Arch Bronconeumol. 2017 May;53(5):263-269. doi: 10.1016/j.arbres.2016.12.011. Epub 2017 Mar 11. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Nov;53(11):657-658.

35.

Slice correspondence estimation using SURF descriptors and context-based search for prostate whole-mount histology MRI registration.

Guzman L, Commandeur F, Acosta O, Simon A, Fautrel A, Rioux-Leclercq N, Romero E, Mathieu R, de Crevoisier R.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:1163-1166. doi: 10.1109/EMBC.2016.7590911.

PMID:
28268532
36.

Is Dose Deformation-Invariance Hypothesis Verified in Prostate IGRT?

Simon A, Le Maitre A, Nassef M, Rigaud B, Castelli J, Acosta O, Haigron P, Lafond C, de Crevoisier R.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):830-838. doi: 10.1016/j.ijrobp.2016.12.011. Epub 2016 Dec 12.

PMID:
28244420
37.

The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning.

Zhu J, Simon A, Haigron P, Lafond C, Acosta O, Shu H, Castelli J, Li B, De Crevoisier R.

Onco Targets Ther. 2016 Dec 12;9:7537-7544. doi: 10.2147/OTT.S116508. eCollection 2016.

38.

Efficient muscle regeneration after highly haemorrhagic Bothrops alternatus venom injection.

Garcia Denegri ME, Teibler GP, Maruñak SL, Hernández DR, Acosta OC, Leiva LC.

Toxicon. 2016 Nov;122:167-175. doi: 10.1016/j.toxicon.2016.10.005. Epub 2016 Oct 6.

PMID:
27720976
39.

Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer.

Leseur J, Roman-Jimenez G, Devillers A, Ospina-Arango JD, Williaume D, Castelli J, Terve P, Lavoue V, Garin E, Lejeune F, Acosta O, De Crevoisier R.

Radiother Oncol. 2016 Sep;120(3):512-518. doi: 10.1016/j.radonc.2016.08.008. Epub 2016 Aug 25.

PMID:
27569847
40.

Erratum: New native South American Y chromosome lineages.

Jota MS, Lacerda DR, Sandoval JR, Vieira PP, Ohasi D, Santos-Júnior JE, Acosta O, Cuellar C, Revollo S, Paz-Y-Miño C, Fujita R, Vallejo GA, Schurr TG, Tarazona-Santos EM, Pena SDj, Ayub Q, Tyler-Smith C, Santos FR; Genographic Consortium.

J Hum Genet. 2016 Jul;61(7):675. doi: 10.1038/jhg.2016.43. No abstract available.

PMID:
27453507
41.

PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal Villi.

Gómez D, Muñoz N, Guerrero R, Acosta O, Guerrero CA.

PPAR Res. 2016;2016:4049373. doi: 10.1155/2016/4049373. Epub 2016 Jun 13.

42.

Leiomyosarcoma of the uterine cervix associated with pregnancy: A case report and review of literature.

Whitcombe DD, Valente PT, Acosta OM, Kost ER.

Gynecol Oncol Rep. 2016 May 31;17:45-8. doi: 10.1016/j.gore.2016.05.012. eCollection 2016 Aug.

43.

Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer.

Gnep K, Fargeas A, Gutiérrez-Carvajal RE, Commandeur F, Mathieu R, Ospina JD, Rolland Y, Rohou T, Vincendeau S, Hatt M, Acosta O, de Crevoisier R.

J Magn Reson Imaging. 2017 Jan;45(1):103-117. doi: 10.1002/jmri.25335. Epub 2016 Jun 27.

PMID:
27345946
44.

MRI to CT Prostate Registration for Improved Targeting in Cancer External Beam Radiotherapy.

Commandeur F, Simon A, Mathieu R, Nassef M, Arango JDO, Rolland Y, Haigron P, de Crevoisier R, Acosta O.

IEEE J Biomed Health Inform. 2017 Jul;21(4):1015-1026. doi: 10.1109/JBHI.2016.2581881. Epub 2016 Jun 16.

PMID:
27333613
45.

Interindividual registration and dose mapping for voxelwise population analysis of rectal toxicity in prostate cancer radiotherapy.

Dréan G, Acosta O, Lafond C, Simon A, de Crevoisier R, Haigron P.

Med Phys. 2016 Jun;43(6):2721-2730. doi: 10.1118/1.4948501.

46.

Inflammatory and oxidative stress in rotavirus infection.

Guerrero CA, Acosta O.

World J Virol. 2016 May 12;5(2):38-62. doi: 10.5501/wjv.v5.i2.38. Review.

47.

Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT.

Dréan G, Acosta O, Ospina JD, Fargeas A, Lafond C, Corrégé G, Lagrange JL, Créhange G, Simon A, Haigron P, de Crevoisier R.

Radiother Oncol. 2016 Jun;119(3):388-97. doi: 10.1016/j.radonc.2016.04.023. Epub 2016 May 9.

PMID:
27173457
48.

New native South American Y chromosome lineages.

Jota MS, Lacerda DR, Sandoval JR, Vieira PP, Ohasi D, Santos-Júnior JE, Acosta O, Cuellar C, Revollo S, Paz-Y-Miño C, Fujita R, Vallejo GA, Schurr TG, Tarazona-Santos EM, Pena SDj, Ayub Q, Tyler-Smith C, Santos FR; Genographic Consortium.

J Hum Genet. 2016 Jul;61(7):593-603. doi: 10.1038/jhg.2016.26. Epub 2016 Mar 31.

PMID:
27030145
49.

Quantification of dose uncertainties in cumulated dose estimation compared to planned dose in prostate IMRT.

Nassef M, Simon A, Cazoulat G, Duménil A, Blay C, Lafond C, Acosta O, Balosso J, Haigron P, de Crevoisier R.

Radiother Oncol. 2016 Apr;119(1):129-36. doi: 10.1016/j.radonc.2016.03.007. Epub 2016 Mar 15.

PMID:
26993416
50.

Bone resorptive activity of human peripheral blood mononuclear cells after fusion with polyethylene glycol.

Manrique E, Castillo LM, Lazala O, Guerrero CA, Acosta O.

J Bone Miner Metab. 2017 Mar;35(2):127-141. doi: 10.1007/s00774-016-0744-0. Epub 2016 Mar 11.

PMID:
26969392

Supplemental Content

Loading ...
Support Center